
While nominal spending was up 1.4%, actual net spending was only 0.6% greater than 2016

While nominal spending was up 1.4%, actual net spending was only 0.6% greater than 2016

Projected growth rates for outsourced work range from 12 to 17%

Proprietary processes combine cryogenic and room-temperature steps for adipose tissue

Vaccines for adult disease states and for tropical diseases expand the market beyond traditional pediatric applications

Colorcon will partner with Applied DNA Sciences for pill-coating taggants

Speed to therapy is a benefit

So-called ‘off the shelf’ CAR-T treatments could change the field just as first products enter commercialization

Supply chain security—with DSCSA compliance—could be a near-term use case, says Accenture

Align Clinical CRO will streamline clinical-study data processes

Pharma logistics gathering highlights supply bottlenecks


Existing ‘pay for performance’ models do not scale up well yet

Patient support (hub) services rise in lockstep with specialty pharmaceutical launches

Data drawn from collaborating sources can benefit the patient journey

Hub services enhance relationships with patients


Forecast is for 3-6% CAGR through 2022

Learn the steps for becoming a Verified-Accredited Wholesaler Distributor®

Wide capacity range combines with CRT, refrigerated and frozen shipping

Deepens focus on logistics for direct-to-patient, cell and gene therapy and clinical trials execution

Thousands of human eggs and embryos may have been lost; meanwhile, industry research facilities shift to predictive maintenance

$67-billion Cigna bid, if permitted, would pull in the last large independent PBM

Will also expands capacity in the EU market

Cardinal’s Diane Pfahl is Industry Leader of the year

Company is also expanding in Australia

Financial analysis shows PBMs’ greater conversion of profits to earnings

AMA calls for more MAT; HDA calls for better sharing of suspicious-order data

Growing emphasis on machine learning for improving data quality

Dohmen Life Sciences Services is joined to a trio of recent acquisitions